Call Us Toll Free: 1-800-388-9993

Abbott Laboratories (ABT)

Available from the Temper Enrollment Service: Yes


Last Update On: 11/05/2013:

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. In August 2013, Abbott Laboratories completed its acquisition of OptiMedica Corporation. In August 2013, Abbott Laboratories completed its acquisition of IDEV Technologies. **Taken From Google Finance**

Industry: Drugs, health care
Minimum Investment: $25.00
Maximum Investment: $150,000/year
Shares to qualify: 1
Recent Price: 42.24
Investing Fee: $0!
Fee for Dividends: $0!

! = Company pays fees

Information is based on an annual survey and updated when company changes become available.

 

FOR MORE
INFORMATION

Click for Español

And a free copy of The Moneypaper's direct investing brochure, please enter your contact information below.

You will also be signed up to receive our twice-monthy stock special.
You can unsubscribe at any time.

* Required Field.